Inactivation of Severe Acute Respiratory Coronavirus Virus 2 (SARS-CoV-2) and Diverse RNA and DNA Viruses on Three-Dimensionally Printed Surgical Mask Materials.
2-Propanol
COVID-19
/ prevention & control
DNA, Viral
/ drug effects
Decontamination
/ methods
Disinfectants
/ pharmacology
Disinfection
/ methods
HIV-1
/ drug effects
Healthy Volunteers
Hot Temperature
Humans
Hydrogen Peroxide
Masks
Personal Protective Equipment
Printing, Three-Dimensional
RNA, Viral
/ drug effects
SARS-CoV-2
/ drug effects
Virus Diseases
/ prevention & control
Virus Inactivation
Journal
Infection control and hospital epidemiology
ISSN: 1559-6834
Titre abrégé: Infect Control Hosp Epidemiol
Pays: United States
ID NLM: 8804099
Informations de publication
Date de publication:
03 2021
03 2021
Historique:
pubmed:
14
8
2020
medline:
31
3
2021
entrez:
14
8
2020
Statut:
ppublish
Résumé
Personal protective equipment (PPE) is a critical need during the coronavirus disease 2019 (COVID-19) pandemic. Alternative sources of surgical masks, including 3-dimensionally (3D) printed approaches that may be reused, are urgently needed to prevent PPE shortages. Few data exist identifying decontamination strategies to inactivate viral pathogens and retain 3D-printing material integrity. To test viral disinfection methods on 3D-printing materials. The viricidal activity of common disinfectants (10% bleach, quaternary ammonium sanitizer, 3% hydrogen peroxide, or 70% isopropanol and exposure to heat (50°C, and 70°C) were tested on four 3D-printed materials used in the healthcare setting, including a surgical mask design developed by the Veterans' Health Administration. Inactivation was assessed for several clinically relevant RNA and DNA pathogenic viruses, including severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and human immunodeficiency virus 1 (HIV-1). SARS-CoV-2 and all viruses tested were completely inactivated by a single application of bleach, ammonium quaternary compounds, or hydrogen peroxide. Similarly, exposure to dry heat (70°C) for 30 minutes completely inactivated all viruses tested. In contrast, 70% isopropanol reduced viral titers significantly less well following a single application. Inactivation did not interfere with material integrity of the 3D-printed materials. Several standard decontamination approaches effectively disinfected 3D-printed materials. These approaches were effective in the inactivation SARS-CoV-2, its surrogates, and other clinically relevant viral pathogens. The decontamination of 3D-printed surgical mask materials may be useful during crisis situations in which surgical mask supplies are limited.
Sections du résumé
BACKGROUND
Personal protective equipment (PPE) is a critical need during the coronavirus disease 2019 (COVID-19) pandemic. Alternative sources of surgical masks, including 3-dimensionally (3D) printed approaches that may be reused, are urgently needed to prevent PPE shortages. Few data exist identifying decontamination strategies to inactivate viral pathogens and retain 3D-printing material integrity.
OBJECTIVE
To test viral disinfection methods on 3D-printing materials.
METHODS
The viricidal activity of common disinfectants (10% bleach, quaternary ammonium sanitizer, 3% hydrogen peroxide, or 70% isopropanol and exposure to heat (50°C, and 70°C) were tested on four 3D-printed materials used in the healthcare setting, including a surgical mask design developed by the Veterans' Health Administration. Inactivation was assessed for several clinically relevant RNA and DNA pathogenic viruses, including severe acute respiratory coronavirus virus 2 (SARS-CoV-2) and human immunodeficiency virus 1 (HIV-1).
RESULTS
SARS-CoV-2 and all viruses tested were completely inactivated by a single application of bleach, ammonium quaternary compounds, or hydrogen peroxide. Similarly, exposure to dry heat (70°C) for 30 minutes completely inactivated all viruses tested. In contrast, 70% isopropanol reduced viral titers significantly less well following a single application. Inactivation did not interfere with material integrity of the 3D-printed materials.
CONCLUSIONS
Several standard decontamination approaches effectively disinfected 3D-printed materials. These approaches were effective in the inactivation SARS-CoV-2, its surrogates, and other clinically relevant viral pathogens. The decontamination of 3D-printed surgical mask materials may be useful during crisis situations in which surgical mask supplies are limited.
Identifiants
pubmed: 32783787
pii: S0899823X20004171
doi: 10.1017/ice.2020.417
pmc: PMC7463154
doi:
Substances chimiques
DNA, Viral
0
Disinfectants
0
RNA, Viral
0
Hydrogen Peroxide
BBX060AN9V
2-Propanol
ND2M416302
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
253-260Subventions
Organisme : NIEHS NIH HHS
ID : P30 ES005605
Pays : United States
Organisme : BLRD VA
ID : I01 BX000207
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI129269
Pays : United States
Organisme : NIAID NIH HHS
ID : P01 AI060699
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007343
Pays : United States
Références
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
3D Print Med. 2016;2:
pubmed: 29974058
Virol J. 2013 Sep 15;10:289
pubmed: 24034697
J Mol Biol. 2020 May 1;432(10):3309-3325
pubmed: 32320687
Materials (Basel). 2020 Jan 09;13(2):
pubmed: 31936429
J Hosp Infect. 2020 Mar;104(3):246-251
pubmed: 32035997
Semin Immunopathol. 2017 Jul;39(5):529-539
pubmed: 28466096
Anaesthesia. 2020 Aug;75(8):1022-1027
pubmed: 32348561
Anal Chem. 2014 Apr 1;86(7):3240-53
pubmed: 24432804
mBio. 2020 Feb 11;11(1):
pubmed: 32047128
J Virol. 1991 Sep;65(9):5029-36
pubmed: 1651421
J Infect Dis. 2017 Nov 27;216(9):1164-1175
pubmed: 28968905
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Infect Control Hosp Epidemiol. 1999 Dec;20(12):821-7
pubmed: 10614606
World Neurosurg. 2013 Sep-Oct;80(3-4):233-5
pubmed: 23871811
3D Print Med. 2020 Apr 27;6(1):11
pubmed: 32337613
Adv Drug Deliv Rev. 2017 Jan 1;108:39-50
pubmed: 27001902
Materials (Basel). 2020 Mar 19;13(6):
pubmed: 32204456
Science. 2020 May 8;368(6491):
pubmed: 32234805
Cell. 2020 Aug 6;182(3):744-753.e4
pubmed: 32553273
Nat Biotechnol. 2014 Aug;32(8):773-85
pubmed: 25093879
Biomed Eng Online. 2016 Oct 21;15(1):115
pubmed: 27769304
Lab Med. 2020 Jul 8;51(4):e45-e46
pubmed: 32386057
J Virol Methods. 2017 Aug;246:51-57
pubmed: 28359770
Materials (Basel). 2020 Apr 24;13(8):
pubmed: 32344688
Sci Rep. 2021 Jan 21;11(1):2051
pubmed: 33479334
J Virol Methods. 2014 Oct;207:232-7
pubmed: 25025814
3D Print Med. 2018 Nov 21;4(1):11
pubmed: 30649688
J Immunol. 2010 Oct 1;185(7):4496-505
pubmed: 20826757
mBio. 2020 May 5;11(3):
pubmed: 32371599
Sci Total Environ. 2020 Jul 10;725:138532
pubmed: 32304970
Pharmaceutics. 2019 Aug 03;11(8):
pubmed: 31382565